229 related articles for article (PubMed ID: 26606448)
1. A highly tumor-specific light-triggerable drug carrier responds to hypoxic tumor conditions for effective tumor treatment.
Park W; Bae BC; Na K
Biomaterials; 2016 Jan; 77():227-34. PubMed ID: 26606448
[TBL] [Abstract][Full Text] [Related]
2. Near-infrared light triggered drug delivery system for higher efficacy of combined chemo-photothermal treatment.
Chen Y; Li H; Deng Y; Sun H; Ke X; Ci T
Acta Biomater; 2017 Mar; 51():374-392. PubMed ID: 28088668
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-responsive polymeric nanoparticles for tumor-targeted drug delivery.
Thambi T; Deepagan VG; Yoon HY; Han HS; Kim SH; Son S; Jo DG; Ahn CH; Suh YD; Kim K; Kwon IC; Lee DS; Park JH
Biomaterials; 2014 Feb; 35(5):1735-43. PubMed ID: 24290696
[TBL] [Abstract][Full Text] [Related]
4. Reactive oxygen species responsive drug releasing nanoparticle based on chondroitin sulfate-anthocyanin nanocomplex for efficient tumor therapy.
Jeong D; Bae BC; Park SJ; Na K
J Control Release; 2016 Jan; 222():78-85. PubMed ID: 26686664
[TBL] [Abstract][Full Text] [Related]
5. Photochemically triggered cytosolic drug delivery using pH-responsive hyaluronic acid nanoparticles for light-induced cancer therapy.
Lee CS; Na K
Biomacromolecules; 2014 Nov; 15(11):4228-38. PubMed ID: 25251731
[TBL] [Abstract][Full Text] [Related]
6. Photosensitizer enhanced disassembly of amphiphilic micelle for ROS-response targeted tumor therapy in vivo.
Dai L; Yu Y; Luo Z; Li M; Chen W; Shen X; Chen F; Sun Q; Zhang Q; Gu H; Cai K
Biomaterials; 2016 Oct; 104():1-17. PubMed ID: 27423095
[TBL] [Abstract][Full Text] [Related]
7. Dual-effect liposomes encapsulated with doxorubicin and chlorin e6 augment the therapeutic effect of tumor treatment.
Peng PC; Hong RL; Tsai YJ; Li PT; Tsai T; Chen CT
Lasers Surg Med; 2015 Jan; 47(1):77-87. PubMed ID: 25559348
[TBL] [Abstract][Full Text] [Related]
8. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
[TBL] [Abstract][Full Text] [Related]
9. Light-activated drug release from a hyaluronic acid targeted nanoconjugate for cancer therapy.
Sun CY; Zhang BB; Zhou JY
J Mater Chem B; 2019 Aug; 7(31):4843-4853. PubMed ID: 31389968
[TBL] [Abstract][Full Text] [Related]
10. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo.
Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J
Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168
[TBL] [Abstract][Full Text] [Related]
11. Redox- and light-responsive alginate nanoparticles as effective drug carriers for combinational anticancer therapy.
Zhang C; Shi G; Zhang J; Niu J; Huang P; Wang Z; Wang Y; Wang W; Li C; Kong D
Nanoscale; 2017 Mar; 9(9):3304-3314. PubMed ID: 28225139
[TBL] [Abstract][Full Text] [Related]
12. Near-Infrared Laser-Triggered, Self-Immolative Smart Polymersomes for in vivo Cancer Therapy.
Tang Q; Hu P; Peng H; Zhang N; Zheng Q; He Y
Int J Nanomedicine; 2020; 15():137-149. PubMed ID: 32021170
[TBL] [Abstract][Full Text] [Related]
13. Enhanced chemotherapeutic efficacy of the low-dose doxorubicin in breast cancer via nanoparticle delivery system crosslinked hyaluronic acid.
Wang Q; Zhong Y; Liu W; Wang Z; Gu L; Li X; Zheng J; Du H; Zhong Z; Xie F
Drug Deliv; 2019 Dec; 26(1):12-22. PubMed ID: 30691317
[TBL] [Abstract][Full Text] [Related]
14. Light-triggered liposomal cargo delivery platform incorporating photosensitizers and gold nanoparticles for enhanced singlet oxygen generation and increased cytotoxicity.
Kautzka Z; Clement S; Goldys EM; Deng W
Int J Nanomedicine; 2017; 12():969-977. PubMed ID: 28203076
[TBL] [Abstract][Full Text] [Related]
15. Targeted delivery of doxorubicin by CSA-binding nanoparticles for choriocarcinoma treatment.
Zhang B; Cheng G; Zheng M; Han J; Wang B; Li M; Chen J; Xiao T; Zhang J; Cai L; Li S; Fan X
Drug Deliv; 2018 Nov; 25(1):461-471. PubMed ID: 29426237
[TBL] [Abstract][Full Text] [Related]
16. GSH-mediated photoactivity of pheophorbide a-conjugated heparin/gold nanoparticle for photodynamic therapy.
Li L; Nurunnabi ; Nafiujjaman ; Lee YK; Huh KM
J Control Release; 2013 Oct; 171(2):241-50. PubMed ID: 23867285
[TBL] [Abstract][Full Text] [Related]
17. Bile acid-conjugated chondroitin sulfate A-based nanoparticles for tumor-targeted anticancer drug delivery.
Lee JY; Chung SJ; Cho HJ; Kim DD
Eur J Pharm Biopharm; 2015 Aug; 94():532-41. PubMed ID: 26149228
[TBL] [Abstract][Full Text] [Related]
18. Light-enhanced hypoxia-responsive and azobenzene cleavage-triggered size-shrinkable micelles for synergistic photodynamic therapy and chemotherapy.
Xu Z; Pan C; Yuan W
Biomater Sci; 2020 Jun; 8(12):3348-3358. PubMed ID: 32458834
[TBL] [Abstract][Full Text] [Related]
19. Bioreducible shell-cross-linked hyaluronic acid nanoparticles for tumor-targeted drug delivery.
Han HS; Thambi T; Choi KY; Son S; Ko H; Lee MC; Jo DG; Chae YS; Kang YM; Lee JY; Park JH
Biomacromolecules; 2015 Feb; 16(2):447-56. PubMed ID: 25565417
[TBL] [Abstract][Full Text] [Related]
20. Robust PEGylated hyaluronic acid nanoparticles as the carrier of doxorubicin: mineralization and its effect on tumor targetability in vivo.
Han HS; Lee J; Kim HR; Chae SY; Kim M; Saravanakumar G; Yoon HY; You DG; Ko H; Kim K; Kwon IC; Park JC; Park JH
J Control Release; 2013 Jun; 168(2):105-14. PubMed ID: 23474029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]